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Abstract
Introduction: In view of the high prevalence of Congenital Hypothyroidism (CH) in Iran, in this study we evaluated the role of iodine in
the aetiology of CH by comparing urine and milk iodine concentrations in healthy and congenitally hypothyroid neonates and their
mothers.
Material and methods: In a cross-sectional study, urinary iodine concentrations (UIC) in newborns with CH, as well as UIC and the milk
iodine concentrations (MIC) of their mothers, were measured and compared with a control group. The lower, mid, and upper range of
UIC for neonates and lactating mothers was considered to be < 150 mg/L, 150–230 mg/L, and > 230 mg/L, and lower, mid, and upper range
of MIC was considered to be < 150 mg/L, 150–180 mg/L, and > 180 mg/L, respectively.
Results: The median UICs in subjects with CH (n = 68) and healthy subjects (n = 179) were 300.5 and 290.5 mg/L, respectively (P > 0.05).
The median UICs in the case and control groups were 150 and 130 mg/L, respectively (P > 0.05). The median MIC in the case group was
higher than in the control group (210 mg/L v. 170 mg/L, P < 0.05).There was a positive correlation between newborn UIC and MIC. There
was no significant correlation between newborn UIC and serum TSH, maternal UIC and maternal MIC, or newborn UIC and serum TSH.
Conclusions: There is no inadequacy in iodine intake in the studied population. Iodine excess could be a possible risk factor for CH, but
there were findings, such as lack of correlation between maternal MIC and UIC, and the median neonatal UIC, which was similar in the
two groups, so, drawing conclusions should be done with some caution and requires further studies.
(Pol J Endocrinol 2010; 61 (4): 371–376)
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Streszczenie
Wstęp: Częste występowanie wrodzonej niedoczynności tarczycy (CH, congenital hypothyroidism) w Iranie skłoniło autorów do oceny roli
jodu w etiologii CH, opierając się na porównaniu jego stężenia w moczu zdrowych noworodków i noworodków z wrodzoną niedoczyn-
nością tarczycy oraz w mleku i moczu ich matek.
Materiał i metody: W tym przekrojowym badaniu zmierzono stężenie jodu w moczu (UIC, urinary iodine concentration) noworodków
z CH oraz UIC i stężenie jodu w mleku (MIC, milk iodine concentration) ich matek, a następnie porównano je z wynikami otrzymanymi
w grupie kontrolnej.
Wartości UIC zmierzone u noworodków i karmiących matek podzielono na 3 kategorie: niskie UIC < 150 mg/l, średnie — 150–230 mg/l
i wysokie > 230 mg/l. Analogiczne kategorie przyjęto dla MIC: niskie < 150 mg/l, średnie 150–180 mg/l i wysokie > 180 mg/l.
Wyniki: Mediana UIC u noworodków z CH (n = 68) i u zdrowych noworodków (n = 179) wynosiła odpowiednio 300,5 i 290,5 mg/dl,
(P > 0,05). Mediana UIC w grupach badanej i kontrolnej wynosiła odpowiednio 150 i 130 mg/l (P > 0,05). Mediana MIC w grupie badanej
była większa niż w grupie kontrolnej (210 mg/l v. 170 mg/l, P < 0,05). Stwierdzono dodatnią korelację między UIC u noworodków i MIC
u ich matek. Nie wykazano wyraźnej zależności między UIC i stężeniem TSH w surowicy u noworodków oraz UIC I MIC u matek.
Wnioski: Spożycie sodu w badanej populacji było prawidłowe. Nadmierna podaż sodu może być czynnikiem ryzyka CH, jednak
w badaniu wykazano brak korelacji między MIC I UIC u matek i podobne wartości mediany UIC u noworodków w obu grupach, dlatego
do sformułowania jednoznacznych wniosków potrzebne są dalsze badania.
(Endokrynol Pol 2010; 61 (4): 371–376)
Słowa kluczowe: wrodzony hipotyreoidyzm, mleko, mocz, jod
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Introduction
Iodine is essential for thyroid hormone synthesis and,
accordingly, is required for normal development,
growth, and metabolism, and it is well known that both
iodine deficiency and iodine excess affect neonatal thy-
roid function [1]. A lack of thyroid hormone for more
than a few weeks during brain development in utero
or during the first years of life may permanently harm
brain function, and breastfed infants are reliant on ade-
quate maternal dietary iodine intake [2]. Adequate ma-
ternal dietary iodine intake is required for normal foet-
al brain development and for the continued neurode-
velopment of breast-fed infants [3–4]. Congenital hy-
pothyroidism is the most common cause of preventable
mental retardation, and around the world the most com-
mon cause of congenital hypothyroidism is iodine de-
ficiency [5–6], but in most of the developed world and
areas of adequate environmental iodine, factors other
than iodine deficiency are responsible for the disorder,
such as genetic factors, thyroid autoimmunity, and io-
dine excess, especially in formerly iodine-deficient ar-
eas [7–9].
Many studies have demonstrated that iodine excess
is a risk factor for CH [10].The foetus and newborn can
be exposed to high maternal iodine concentrations ei-
ther by crossing the placenta perinatally, or postnatally
by secretion of iodine into breast milk [11]. Iodine ex-
cess has an antithyroid effect due to the so-called Wollf-
-Chaikoff effect; it blocks the uptakes of iodine by the
thyroid gland and leads to reduced T4 and increased
TSH [12–13].
Major progress has been made toward elimination
of iodine deficiency in Iran, and according to the study
of Azizi et al., Iran has reached a sustainable control
program for iodine deficiency [14], as also reported by
the WHO [15].
Screening programs for congenital hypothyroidism,
in addition to early detection and treatment of the dis-
order, provide the opportunity to investigate the aeti-
ology and the pathogenesis of CH. According to the
reports of CH screening in Iran, CH is more prevalent
in this region. It is detected at a rate of 1 per 914 live
births in Tehran, 1 per 1433 in Fars, and 1 per 370 in
Isfahan [16–18]. Nowadays, CH screening is established
in Iran as a nationwide program, but considering its high
prevalence it seems that it is necessary to investigate
the possible contributors of CH in our region. There
have been studies in Isfahan and in other parts of the
country which have indicated that urine and milk iodine
concentrations are within the acceptable range [19–21],
but in Isfahan at the time of CH screening, the status of
iodine in newborns and their mothers had not studied
been. Therefore, the aim of this study was to determine
the role of iodine, as a major environmental risk factor,
in the aetiology of CH in Isfahan by comparing urine
and milk iodine concentrations in healthy and congen-
itally hypothyroid neonates and their mothers.
Material and methods
During this cross-sectional study, from September 2006
to February 2007, urinary iodine concentrations (UIC)
in newborns with CH as well as UIC and Milk iodine
concentrations (MIC) of their mothers were measured
and were compared with a control group. Subjects in
both the case and control groups were selected by a sim-
ple sampling method from newborns and their moth-
ers during a CH screening program in Isfahan. Accord-
ing to the CH screening protocol, neonates with abnor-
mal screening results (TSH > 10 mIU/L by heel-prick
method) were re-examined, and newborns with abnor-
mal T4 (< 6 mg/dL) and TSH (> 10 mIU/L) levels on
their second measurement were diagnosed as CH pa-
tients and referred to Isfahan Endocrine and Metabolism
Research Centre for treatment and regular follow up [18].
Seventy-six CH patients and their mothers were invit-
ed (case group), and 184 neonates and their mothers
with normal screening results were also invited (con-
trol group). The participants in the control group were
matched to the case group according to age and socio-
economic condition. All selected neonates were exclu-
sively breast fed until laboratory measurement. Moth-
ers with a history of pre- or postnatal exposure to ex-
cessive amounts of iodine, such as thyroid hormone
ingestion or use of iodine-containing topical antisep-
tics, maternal consumption of goitrogens and/or thy-
roid affecting medications, known systemic disorders,
palpable goiter, or thyroid disorder and preterm infants
(< 37 weeks’ gestation), neonates with history of hos-
pitalization, exchange blood transfusion because of neo-
natal hyperbilirubinaemia, were excluded. Written con-
sent was obtained from all participants. Blood and urine
samples were taken from newborns. Urine, blood, and
milk samples were also collected from the mothers of
the newborns. Neonatal and maternal urine and ma-
ternal breast milk samples were obtained on days 14 to
28 from birth. Spot urine and breast milk samples were
collected for the measurement of iodine concentrations.
Urine samples were kept at –20°C until assayed at the
end of the study. Thyroid function tests (TSH and T4)
were performed in mothers also.
Lower, mid, and upper ranges of UIC for neonates
and lactating mothers was considered to be < 150 mg/L,
150–230 mg/L, and > 230 mg/L and lower, mid, and up-
per ranges of MIC were considered to be < 150 mg/L,
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150–180 mg/L, and > 180 mg/L, respectively. In addition,
we considered the recommendations of the WHO,
UNICEF, ICCIDD [22], and one other study in Iran [21]
by determining the proportion of participants with UIC
< 50 mg/L, 50–100 mg/L, and 100–150 mg/L and MIC
< 50 mg/L and 50–150 mg/L.
Laboratory methods
After acid digestion of urine and alkaline incineration
of milk samples, iodine concentrations were determined
by the Sandell–Kolthoff method [23]. Serum TSH and
T4 concentrations were determined by ImmunoRadio-
MetricAssay (IRMA) and RadioImmunoAssay (RIA)
using Kavoshyar (Tehran-Iran) kits.
Statistical analysis
Data were analyzed using SPSS 11.0 for Windows. c2,
paired t-test, Wilcoxon, and Pearson correlation, and
Spearman’s correlation tests were used for statistical
analysis. P value less than 0.05 was considered statisti-
cally significant. The normal distribution of continuous
variables was verified by Kolmogorov-Smirnov test.
Results
In this study, from the invited CH neonates and moth-
ers, 68 CH neonates with normal thyroid ultrasonogra-
phy and their mothers and 179 neonates and their moth-
ers in the control group enrolled in the study. Mean
maternal age in the case and control groups were
26.2 ± 6.1 years (19–35) and 25.9 ± 5.7 years (18–34),
respectively (P > 0.05). Mean age of neonates in the
case and control groups at the time of the study were
20.8 ± 7.2 days and 16.2  ± 4.8 days, respectively (P < 0.05).
Characteristics and laboratory data (mean = /– SD or
median) of the case and control group are presented in
Table I. The median of newborns and mothers UIC and
mothers MIC (both case and control) was 300 mg/L
(10–460), 130 mg/L (20–400), and 180 mg/L (60–370), re-
spectively. The proportions of breast milk iodine and
maternal and neonatal urine iodine according to our
classification are presented in Tables II and III.
According to the Pearson test, there was positive
correlation between newborn UIC and MIC (P < 0.05,
r = 0.015) and there was no correlation between new-
born UIC and serum TSH. Maternal UIC did not corre-
late with maternal MIC, newborn UIC, and serum TSH.
Discussion
In this study, the effect of iodine status in newborns
and their mothers, the two sensitive groups in this field,
on the aetiology of CH was studied during a CH screen-
ing program in Isfahan. The findings of our study indi-
cated that the median of UIC in the two groups and
MIC was within the acceptable range for an iodine suf-
ficient area, a fact which was also reported earlier [14].
It seems that iodine excess is thought to contribute to
the high prevalence of CH in this region because both
the median of mothers MIC in the case group and the
proportion of mothers with iodine excess according to
our classification was higher than the control group.
Within a population, newborns and pregnant or lac-
tating women are the groups most vulnerable to iodine
deficiency. According to the latest report from the
NHANES study and another study in China, despite
an effective iodized salt program, pregnant and lactat-
ing women in some areas may still risk deficiency and
Table I. Characteristics and laboratory data of case and control groups
Tabela I. Charakterystyka grup badanej i kontrolnej oraz wyniki badań laboratoryjnych w obu grupach
Case group Control group P value
n = 68 n = 179
Mean ± SD Median Mean ± SD Median
Weight [gr]* 2958.2±482.4 2800.0 (2400–4100) 3228.4±468.5 3070.0 (2700–4070) NS
Height [cm] 52.9±3.1 52.5 (46–59) 52.1±1.6 52.0 (46–58) NS
Head circumference [cm] 37.2±1.4 37.5 (31–39) 37.6±0.9 37.5 (33–39) NS
Screening TSH [mIU/L] 22.3±27.2 11.5 (10–100) 6.4±2.4 5.4 (4–22) 0.00
TSH mother [mIU/L] 2.3±1.8 2.0 (1.1–6.4) 1.3±1.0 1.00 (1–6.6) 0.00
T4–mother* [mg/dL] 9.2±2.9 8.5 (6.2–12.8) 9.4±2.3 9.2 (6.5–13.1) NS
Urine iodine newborn [mg/L] 280.4±120.0 300.0 (10–420) 280.6±100.9 290.5 (30–360) NS
Urine iodine mother [mg/L] 160.9±100.1 150.0 (20–400) 140.4±70.4 130.0 (20–400) NS
Milk iodine mother [mg/L] 220.6±80.1 210.0 (70–370) 180.1±50.3 170.0 (60–320) 0.00
*distribution was normal; mean was compared
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need further supplements [24, 25]. Studies carried out
in Iran after the salt iodization program have indicated
adequate UIC and MIC among pregnant and lactating
women and newborns [19–21]. Ordookhani et al., in
a similar study among healthy neonates and their moth-
ers, reported that median UIC and MIC was within the
appropriate range [26].
The median breast Milk iodide level in a 1984 sample
of 37 U.S. women was 178 mg/L [27] and 155 mg/L in an-
other study in Australia [28]. Gons et al., in their study
among 151 Dutch newborns with and without CH, re-
ported that the median value of UIC was 31 mg/24 h [29].
In our study, the median UIC in all neonates and
their mothers was not different in the case and control
groups, but the median MIC was significantly higher
in mothers of CH neonates, and it was in the upper
range of MIC values (180). It was higher than the two
previously mentioned studies in Iran [21, 26], and it was
similar to the median MIC in US women [27]. The pro-
portion of neonates and mothers with upper range of
iodine, both in the case and control groups, was higher
than those with lower range, and iodine excess was
more prevalent in mothers of hypothyroid neonates
than in the control group, which indicates the possible
role of iodine excess in the aetiology of CH. In the study
of Bazrafshan et al.,UIC < 100 mg /L and MIC < 50 mg /L
was presented in 16% and 19% of their studied popula-
tion, respectively, which was higher than in our study
[21].Ordookhani et al. reported that MIC was < 150,
150–180, and > 180 mg/L in 52.4, 11.9, and 35.7% of moth-
ers, respectively. Compared with our results, iodine
excess and deficiency was lower and higher, respective-
ly, in the case and control groups [26]. The proportion
of different neonatal UIC ranges was similar to those
seen in our study, but in the case of maternal UIC clas-
sification, in our study UIC < 150 and > 230 were low-
er and higher, respectively.
The difference between our results and other stud-
ies in Iran may be due to the fact that our study was
held later, so the duration of using iodized salt was long-
er; however, it may also be explained by differences in
genetic background, environmental factors, and the dif-
ferent biochemical, clinical, and epidemiological methods
which have been applied, especially for iodine measure-
ment and classification of iodine range. Despite increas-
ing numbers of studies examining UIC and MIC, no con-
sistent recommendations have been made for optimal lev-
els of iodine in breast milk or urine in infants and in preg-
nant and lactating women [2, 30]. In the current study,
iodine range classification was a combination of WHO,
UNICEF, and ICCIDD recommendations and prior stud-
ies which were performed in our region [21, 22].
There are controversial results regarding the effect
of iodine excess on CH: some studies demonstrated that
Table II. Proportions of different values of urinary iodine in case and control groups
Tabela II. Odsetek osób w grupach badanej i kontrolnej, u których stężenie jodu w moczu mieści się w poszczególnych
przedziałach wartości
Urinary Neonates Neonates Mothers Mothers
iodine in case group in control group in case group in control group
concentration n (%) n (%) n (%) n (%)
[mg/L]
< 50 1 (1.6%) 2 (1.2%) 3 (4.8%) 2 (1.2%)
< 100 2 (3.2%) 5 (3.0%) 15 (24.2%) 34 (20.7%)
100–150 8 (12.9%) 13 (7.9%) 13 (21%)* 60 (36.6%)
150–230 13 (21.0%) 41 (25%) 23 (37.1) 49 (29.9%)
≥ 230 39 (62.9%) 105 (64%) 11 (17.7%) 21 (12.8%)
62 (100%) 164 (100%) 62 (100%) 164 (100%)
*P = 0.02
Table III. Proportions of different values of breast milk iodine
in case and control groups
Tabela III. Odsetek osób w grupach badanej i kontrolnej,
u których stężenie jodu w mleku mieści się w poszczególnych
przedziałach wartości
Breast milk Mothers in Mothers in
iodine concentration case group control group
[mg/l] n (%) n (%)
< 50 0 (0%) 0 (0%)
50–150 8 (12.9%)* 45 (27.4%)
150–180 10 (16.1%) 41 (25%)
≥ 180 44 (71%)** 78 (47.6%)
62 (100%) 164 (100%)
*P = 0.02
**P = 0.001
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it causes a transient form of CH [31] but others propose
that hyperthyrotropinaemia as a result of excessive io-
dine in some cases might not be transient [32]. In an
aetiological study of transient CH in Iran, Ordookhani
et al. reported that the occurrence of the most frequent
findings among transient CH patients was iodine con-
tamination and excessive UIC [33]. Whereas, according
to the study of Nishiyama et al., excessive iodine intake
in mothers results in persistent hyperthyrotropinaemia
[32]. In our study, the studied neonates in the case group
consisted primarily of diagnosed CH patients with nor-
mal thyroid ultrasonography.
In this study there was no correlation between neo-
natal serum TSH concentration and neonatal or mater-
nal UIC or MIC, which was in accordance with the study
of Ordookhani et al. The findings of Chan et al. were
different to those of our study; they reported that neo-
natal TSH levels were positively correlated with higher
breast milk iodine but that there was no significant cor-
relation between neonatal TSH levels and the mother’s
urine iodine content, as in our study [34]. The differ-
ences may be due to the fact that breast milk iodine was
significantly correlated with urine iodine in micrograms
per gram of creatinine but not with urine iodine mea-
sured in micrograms per litre, and in this study both
UIC and MIC were measured in micrograms per litre.
In addition, UIC in spot urine samples is not a good
indicator of neonatal thyroid function [20].
In our study, the median MIC was significantly high-
er in the case group and there was a positive correla-
tion between MIC and neonatal UIC, but the median of
neonatal UIC was not significantly different in the case
and control groups. This may be explained by the fact
that during the breast feeding period iodine is concen-
trated in milk glands more than before the breast feed-
ing period. This will cause a significant increase in io-
dine concentration in milk following a small increase in
the iodine content of the whole body. This may gradu-
ally result in a higher intake of iodine by the newborn,
and an inhibitory effect of iodine (Wolf Chiakoff Effect)
may cause CH [12, 35, 36]. Another explanation is that
especially severe CH patients drink less milk, giving a
reduction in urinary iodine excretion and also in CH
patients with thyroid agenesis iodine absorption from
the intestinal tract decrease [37].
The age at collection also influences urinary iodine
excretion [38].The mean age of collection for the case
group was 20.8 days and 16.2 days for the control group.
It was higher in the case group because it takes time
after recall to make a final diagnosis of CH. However,
by analysis of covariance, we calculated that the differ-
ence in the age of collection had no effect on the UIC of
the two studied groups. Nevertheless, according to
some studies, although iodide levels in breast milk cor-
relate with dietary iodine, iodide levels in breast milk
do not correlate with the age of the infant (i.e. stage of
lactation) [27].
There was no correlation between maternal UIC and
MIC in our study, which was in contrast to the results
of Bazrafshan et al. and Ordookhani et al.
In conclusion, our findings indicate that iodine ex-
cess could be a possible risk factor for CH. However,
there were findings, such as lack of correlation between
maternal MIC and UIC, the median neonatal UIC which
was similar in two groups, etc., which were mentioned,
and although we have an explanation for the findings,
it seems that drawing conclusions in this field should
be done with some caution. So, we recommended that
further studies with larger sample sizes are needed, and
we should also investigate the source of iodine excess.
In addition, in order to draw accurate conclusions in
the field of CH aetiology in our community, we should
study the role of genetics and autoimmunity, in which
iodine excess could also be responsible.
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